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ABSTRACT
Tuberculosis commonly involves the CNS, During drug treatment of CNS tuberculosis paradoxical response (PR) may 
occasionally occur. The term “paradoxicalresponse”refers to the development of previously nonexistent tuberculosis 
lesions or worsening of preexisting lesions during antituberculosis treatment( ATT). Etiology is still not clear but delayed 
type hypersensitivity and alteration in immune system is thought to be a cause. Continued treatment improves PR 
without severe sequelae. We report a 41 year-old female patient with tuberculous meningitis(TBM) who developed 
brainstem tuberculomaduring the course of ATT, after about 9 months of treatment as a paradoxical response to ATT. 
Early identification, continuation of ATT with steroids and ventriculoperitoneal shunting to relieve raised intracranial 
pressure resulted in complete recovery of our patient. Clinicians should be aware of this phenomenon as it can lead 
to clinical worsening as late as 9 months. The objective of this case report is to increase knowledge of clinicians about 
this phenomenon and also to report its such late occurrence.
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INTRODUCTION
Paradoxical reaction to ATT is a common phenomenon 
andmay affect up to 25% of patients1.It is defined as 
a transient worsening of disease, at a pre-existing site, 
or the development of new tuberculous lesions in a 
patient who initially improved on anti-tubercular 
therapy2. This phenomenon is more commonly 
associated with extrapulmonary tuberculosis2. 
Possible mechanisms include a strengthening of the 
host’s delayed hypersensitivity response, and an 
increased exposure to mycobacterial antigens 
released as bacilli are killed by effective 
chemotherapy3. The paradoxical response can occur 
as an intracranial tuberculoma, pleurisy, pericarditis, 
lymphedenopathy, contralateral new parenchymal 
lesions,or the progression of the preexisting lesions4. 
Its early identification is important and it should not 
compel the clinicians to modify or discontinue theATT. 
We report such a case of paradoxical reaction in a 
41year old female patient who during the course of 
treatment of tuberculous meningitis developed a life 
threatening mid brain tuberculoma after about 9 
months of treatment with ATT.demonstrated 
atfundoscopy. On admission, laboratory investigations 
showed hemoglobin 8 g/dl, white blood
CASE REPORT 
A 41 year old lady was admitted to us with history 
of headache,low grade fever for past 15 days and 
drowsiness for past 3 days.On examination, she 
had a GCS of 13/15, bilateral sixth nerve 
palsy,bilateralpapilloedema on fundoscopy and 
nuchal rigidity. She was diagnosed as 
havingtuberculous meningitis based on 
cerebrospinal fluid examination findings which 
showed Pleocytosis,570white blood cells, out of 
which 88% were lymphocytes,raised(121 
mg/dl)proteins and low glucose(25mg/dl).Her 
initial CT scan brain was normal.She was started 
onATT. Patient showed a favourable response to 
ATT in the form of clinical improvement.Fever 
settled and she was discharged. However, during 
the course of treatment,after about 9 months of 
therapy, she developed recrudescence of fever and 
developed an acute onset headache followed by 
drowsiness,though she was fully compliant with 
treatment and there was nothing to suggest drug 
resistance as she showed dramatic initial 
improvement with ATT. Her CT scan was done 
which showed acute hydrocephlous and a ring 
enhancing lesion mid brain. MRI brain with 
contrast showed two ring enhancing foci in the mid 
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brain as shown in Figure 1. On MRI spectroscopy 
the lesion showed high lipid peaks further 
suggesting possible etiology being tuberculoma 
brainstem as shown in figure 2. She was continued 
on ATTandhigh dose steroids were 
added.Ventriculoperitoneal Shunting was also 
performed as the condition was life threatening 
and she had an acute hydrocephalous with signs of 
raised intacranialpressure.Again the patient 
showed marked clinical recovery.She was 
continuously followed up inoutpatientdepartment. 
Her CT scan repeated 2 months later showed 
marked regression in the size and almost complete 
resolution in the enhancement pattern and 
perilesional edema. ATT was given for complete 18 
months.The further course of treatment being 
uneventful and ended with complete recovery from 
the illness.
DISCUSSION
In many cases tuberculosis can worsen despite 
aggressive ATT,a condition commonly seen in countries 
like ours and if other causes like poor compliance to 
treatment and drug resistance are ruled out, this can 
be attributed to a phenomenon called paradoxical 
reaction which is as clinical or radiological worsening of 
preexisting tuberculous lesions or the development of 
new lesions following the initiation of active ATT. It can 
include the development of intracranial tuberculomas, 
as in our patient, worsening of existing lesions or 
development of new lesions in the lymph nodes, and 
various other manifestations4. Its time of occurrence
is variable.It may occur as early as within 3 to12 weeks 
after the initiation of ATTor may be delayed up to18 
months4as in our patient where it occurred after 9 
months. It is important for clinicians to recognize 
paradoxical tuberculous reactions as inflammatory 
responses to treatment, and to understand that they do 
not necessarily indicate drug resistance or an 
inadequate response to therapy5.It was not the case of 
drug resistance as our patient has excellent clinical 
recovery after starting ATT and later on as well, she 
recovered completely with the same first line ATT. 
It should be noted that PR is a diagnosis of exclusion 
and it poses a particular problem in country like ours 
where it is difficult to differentiate from conditions such 
as drug resistance, poor compliance to drug therapy, 
concomitant diseases, poor drug absorption, where 
disease is common and drug susceptibility testing is not 
available. It is also believed that onset of PR may 
depend on the host immune response, virulence of 
tubercle bacilli, antigen load, site of infection, and 
effects of chemotherapy5 The mechanism of PR
has not clearly been defined to date, although it is 
believed that, the immune response against 
mycobacterial proteins may be enhanced and cause a 
local hypersensitive reaction when active ATT is initiated 
and immunosuppression declines6. Its identification
should not be delayed as it may manifest as a life 
threatening condition as in our patient.Themainstay of 
the treatment is the continuation of ATT and clinicians 
should be aware of this phenomenon and its such late 
occurrence and itshould not compel them to modify or 
discontinue ATT5. Some reports suggest the use of 
systemic steroids as an adjuvant treatment modality for 
PR6.The benefit of corticosteroid therapy for PR is 
apparent in intracranial tuberculomashoweveruseof 
steroids is somewhat controversial in other situations 
such as lymph node tuberculosis6. Previously it was
thought to be an entity seen more commonly in HIV 
coinfected tuberculous patients who are 
simultaneously treated with antiretroviral therapy but it 
has been seen to occur in both HIV non infected and 
coinfected patients.7 Occurrence however is rare in 
nonimmunocompromisedpatients.In a study it has also 
been reported to occur in up to 11.1% of HIV-negative 
patients during treatment for TB2. In cases of 
intracranial lesions, surgical treatment in form of 
craniotomy or shunt operations can be performed to 
decompress the increased intracranial pressure, 
provided the development is acute and it has been 
identified early.The mortality of tuberculosis associated 
immune reconstitution syndrome has been estimated to 
be 3.2% within a recent meta-analysis8.
CONCLUSION
In summary, PR is not uncommon during treatment of 
TBM in nonimmunocompromised patients and can occur 
as late as after 9 months of ATT. Its prompt identification 
and management is crucial and its knowledge and 
awareness among neurologists is of utmost importance.
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resolution in the enhancement pattern and 
perilesional edema. ATT was given for complete 18 
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Fig 1. MRI T1 weighted axial section post contrast
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Fig 2. MRSpectroscopy showing lipid peak suggesting it to be tuberculoma.
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1.3. Pathophysiology and risk factors:
The shoulder complex consists of four separate joints, 
which afford it incredible mobility in all planes of 
motion, but at the expense of its stability. The 
glenohumeral joint relies on the integrity of muscular 
and capsule-ligamentous structures rather than bony 
conformation for its stability. The shoulder stability
depends on static and dynamic stabilizers.The static 
stabilizers are glenoid labrum, glenohumeral and 
coracohumeral ligaments. The dynamic stabilizers 
include the deltoid and rotator cuff muscles which work 
in a fine balance to elevate the arm and keep the 
humeral head in glenoid fossa. During the initial phase 
of post stroke hemiplegia, these muscles becomes 
flaccid. This low tone makes the surrounding structures 
more susceptible to damage and results in altered 
alignment of scapula and humerus. During this phase, 
dynamic stabilizers are not functioning and reliance is 
on static stabilizers, which overstretch due to weight of 
the arm in dependent position. The humeral head 
displaces inferiorly and anteriorly by a combination of 
loss of normal shoulder muscle activity and the weight 
of the upper limb secondary to gravitational pull, which 
stretches the joint capsule, muscles, tendons and 
ligaments.  Improper positioning in bed, lack of support 
while the patient is in the upright position or pulling on 
the hemiplegic arm when transferring the patient can 
further contribute to glenohumeral subluxation. 
Significant shoulder pain occurs within 6 months after 
stroke and there is an increased risk in patients with 
shoulder subluxation.  Huang et al evaluated shoulders 
of post stroke hemiplegic patients with musculoskeletal 
ultrasound. They found that acute stroke patients with 
poor upper limb motor function were more vulnerable 
to soft-tissue injuries during rehabilitation, and a higher 
incidence of shoulder subluxation and higher frequency 
of shoulder pain were found in this group of patients. 
2. ASSESSMENT OF SHOULDER SUBLUXATION:
Shoulder subluxation can be assessed by following 
three methods 
2.1. Clinical assessment
Assessment of shoulder subluxation includes 
inspection of the shoulder for sulcus sign. (Figure 1) 
Measurement of subluxation of shoulder can be carried 
out by following three clinical methods. However these 
clinical methods are examiner dependent and may lack 
precision, and may not detect small changes in 
glenohumeral displacement. 
2.1.1. The number of finger breadths that can be 
inserted between the inferior aspect of the acromion 
and the superior aspect of the humeral head (Figure 2)
Figure 1 Sulcus Sign
Figure 2 Palpation method to assess the inferior 
subluxation of glenohumeral joint
2.1.2. The distance between the inferior border of the 
acromion and the upper border of the humeral head 
can be measured by calipers or a tape to assess arm 
length discrepancy.
 
2.1.3. Use of thermoplastic jig, which is an L-shaped 
device constructed of thermoplastic material with a 
tape measure. Landmarks are the same as the 
anthropometrical evaluation that uses a tape or a 
caliper. 
2.2.Radiological assessment
Radiographic measurements are considered a standard 
measurement for evaluation and have been used in 
several studies to assess the effectiveness of therapy or 
1. INTRODUCTION
Stroke is the third leading cause of death globally and 
an important cause of acquired adult impairment. It is 
a serious and disabling global health-care problem. 
Stroke and transient ischemic attacks (TIA) are highly 
prevalent in Pakistan. No large scale, epidemiological 
studies have been conducted in Pakistan to determine 
the true incidence of stroke in the country. A 
community based survey in Karachi urban area 
estimated the prevalence of stroke and transient 
ischemic stroke to be 21.8%. Many post stroke 
complications have been documented in the literature 
including pain, spasticity, pressure ulcers, urinary tract 
infections, deep vein thrombosis, aspiration pneumonia 
and hemiplegic shoulder pain.  Shoulder subluxation is 
an important complication of stroke, which is mostly 
unrecognized and untreated in Pakistan. Aim of this 
review article is to raise the awareness of this 
somewhat preventable complication among allied 
healthcare professionals and summarize the current 
literature on the epidemiology and pathophysiology, 
evaluation and management strategies of post stroke 
shoulder subluxation. 
1.1 Definition:
Glenohumeral subluxation is defined as “increased 
translation of humeral head relative to the glenoid 
fossa”. The hemiplegic shoulder shows changes in the 
mechanical integrity of the glenohumeral joint causing a 
palpable gap between the acromion and humeral head.
1.2. Epidemiology
Shoulder subluxation, is a frequent complication in post 
stroke patients. It is reported to be present in 17 to 81 
% of patients following stroke, most commonly occuring 
during the flaccid stage. Glenohumeral subluxation 
(GHS) is associated with development of shoulder pain 
(SP), delayed motor recovery of upper extremity and 
should be treated in acute stage of hemiplegia. The 
reported incidence of shoulder pain varies from 48 to 
64%6, which can result in significant disability. Although 
it can occur as early as 2 weeks post stroke, an onset 
time of 2-3 months post stroke is more typical.6 
Although the impact of Glenohumeral subluxation (GHS) 
on the development of shoulder pain and upper-limb 
functional recovery has not been completely explained, a 
number of authors consider GHS an important source of 
shoulder pain. 
development of GHS over time. Generally, the X ray 
approach has been shown to be reliable and valid. 
Glenohumeral subluxation can be assessed by single 
antero-posterior radiograph of the affected shoulder. 
The other methods include plane of the scapula 
method and the calculation of three-dimensional 
distances by two X rays (at 0° and at 45° or at 30° to 
the coronal plane). 13
2.3 Ultrasonographic assessment:
The assessment of shoulder subluxation by 
musculoskeletal ultrasound is becoming increasingly 
popular. Ultrasound can detect minor asymmetry (≤0.5 
cm) and has the potential advantage over the 
fingerbreadth palpation method of identifying patients 
with minor subluxation. The lateral distance (LD) is 
measured from the lateral border of the acromion to 
the greater tuberosity of the humerus. 
Ultrasonographic measurement of Acromion-Greater 
tuberosity (AGT) distance demonstrates excellent 
intra-rater reliability for a novice rater. Inter-rater 
reliability of ultrasonographic measurement of AGT also 
demonstrates good reliability between novice and 
experienced raters. 
3 Impairments Associated with shoulder 
subluxation:
Shoulder subluxation may be associated with several 
impairments and complications as follows
3.1 Shoulder pain:
It has been suggested that if not corrected, a pattern of 
traction on the flaccid shoulder will result in pain, 
decreased range of motion and contracture. However, 
not all patients with a subluxed hemiplegic shoulder 
experience shoulder pain and its contribution to the 
development of HSP is debatable. Paci et al. suggested 
that pain associated with subluxation is probably 
present later after stroke since “fibrous changes or 
injury can occur in connective tissue of the ligaments 
and joint capsule due to incorrect alignment between 
the humerus and the scapula”.13 Shoulder subluxation 
is the second major cause of HSP after adhesive 
capsulitis.11 It has been suggested that subluxation 
causes shoulder pain by overstretching the soft tissues 
(such as the capsule, ligaments and muscles) 
surrounding the shoulder. Some studies describe an 
association between shoulder subluxation and pain11, 
while others do not support the role of shoulder 
subluxation in the development of pain. An arthroscopic 
study found that the causes of hemiplegic shoulder 
pain are complex and that shoulder subluxation is one 
of the major causes. 
3.2. Poor upper limb function and Rehabilitation 
outcomes
Shoulder subluxation is a major challenge in the 
rehabilitation of stroke patients. It may not only affect 
the upper limb treatment process, but can also lead to 
additional complications such as pain, which can 
further delay the recovery of function. Shoulder pain 
can negatively affect rehabilitation outcomes,as good 
shoulder function is a prerequisite for successful 
transfers, maintaining balance, performing activities of 
daily living and for effective hand function. GHS can 
interfere with rehabilitation and has negative effects on 
motor function recovery . One can predict with 98% 
accuracy, which are the patients who will develop HSP 
on the basis of three factors which are strongly 
associated with shoulder pain including positive Neer 
test, moderate  or greater shoulder pain during the 
performance of the hand behind the neck maneuver 
and a reduction in external rotation of shoulder joint 
greater than 10 degrees.
3.3. Reflex sympathetic dystrophy
There is evidence to suggest that shoulder subluxation 
is associated with reflex sympathetic dystrophy. 
Therefore, its prevention should be an important part of 
upper limb rehabilitation.
3.4. Soft tissue injury
Acute stroke patients with poor upper limb motor 
function are more vulnerable to soft-tissue injuries 
during rehabilitation, higher incidence of shoulder 
subluxation and higher frequency of shoulder pain.20
There is a higher percentage of tendonitis in hemiplegic 
shoulders than the unaffected shoulder. The biceps and 
the supraspinatus tendons are major sites of 
soft-tissue injury and lesions. Acute stroke patients with 
poor upper limb motor function, combined with 
impaired sensation, shoulder spasticity and 
subluxation, have a higher prevalence of shoulder 
soft-tissue injuries (85%) and hemiplegic shoulder pain 
(67%).20 Once spasticity develops, the severity of 
shoulder pain and subluxation worsens.
4. Management:
The management of shoulder subluxation after stroke 
starts with preempting its occurrence especially if the 
risk factors, mentioned earlier, are present in the 
hemiplegic patients. Preventing the development of 
shoulder subluxation is considered an important part of 
stroke management and rehabilitation.
4.1. Prevention: 
During the initial flaccid stage of hemiplegia, the 
involved extremity should be adequately supported or 
the weight of the arm might result in shoulder 
subluxation. Education and training for the patient, 
family/caregiver and clinical staff on how to correctly 
handle and position the affected upper limb is 
mandatory.29
4.2. Positioning
Low tone shoulder should be managed by proper 
positioning using pillows, slings, lap trays. Slings should 
be worn during transfers or ambulation only. They 
should be removed during sitting or in bed. In sitting, 
shoulder must be positioned in slight flexion, abduction 
and external rotation; and hand in open weight bearing 
position. Particular attention should be paid to proper 
positioning of pelvis and trunk alignment as Proximal 
stability of the trunk is a pre-requisite for distal limb 
mobility. Since lap trays are not widely available in 
Pakistan so authors recommend use of pillow placed 
under the forearm to prevent and manage shoulder 
subluxation. (Figures 3 and 4)
Figure 3. Shoulder without support while sitting
Figure 4. Shoulder with support under forearm
4.3. Strapping/ Slings
There is insufficient evidence to conclude whether 
slings and wheelchair attachments prevent subluxation, 
decrease pain, increase function, or adversely increase 
contracture in the shoulder after stroke.  There is some 
evidence that strapping the affected shoulder delays 
the onset of pain but does not decrease it. There is also 
some evidence that strapping does not increase 
function nor adversely increase contracture. 
Slings are generally simpler for caregivers to use than 
functional electrical stimulation (FES) or strapping, and 
they can be combined with the other treatments. 
Although formal shoulder sling prescription is low (28%) 
but it is commonly used by patients with post stroke 
subluxation (81%). Shoulder Supports have various 
purposes i.e., realigning scapular symmetry, supporting 
the forearm in a flexed arm position, improving 
anatomic alignment with an auxiliary support, or 
supporting the shoulder with a cuff. The use of slings 
has been considered a contraindication by some 
authors because slings can facilitate an increase in 
flexor tone and synergistic patterns, cause reflex 
sympathetic dystrophy, restrain functional recovery, 
obstruct arm swing during walking, and for some, 
impair body image.34 When prescribing shoulder slings 
to a post stroke hemiplegic patients following should be 
considered
• Ensure a Proper fit that promotes proper
 glenohumeral alignment since poor alignment 
 can contribute to increased flexion synergy.
• The sling should not interfere with patient
 function and should be relatively easy to don 
 and doff.
• It should not create new problems
 (e.g., edema in the dependent hand), 
 contribute to synergy patterns, or cause 
 scapulohumeralmalalignment.
There is conflicting evidence regarding strapping the 
shoulder to prevent or manage subluxation with most of 
the research articles and systematic reviews do not 
favor the use of slings.
4.4. Kinesiotaping. 
Kinesiological taping (KT)can be used to prevent GHS 
or improve symptoms associated with shoulder pain. 
The use of taping method in conjunction with an 
established rehabilitation program may play an 
important role in the reduction of post stroke shoulder 
pain, soft tissue inflammation, muscle weakness, and 
postural malalignment. Kinesiotape may improve the 
position of the glenohumeral joint and may provide the 
proprioceptive feedback to achieve proper body 
alignment.  These factors are fundamental when 
exercises to restore the upper extremity functions are 
performed. The use and the position of the upper 
extremity following a stroke affect not only the patients’ 
ability to reach, hold, and manipulate an object, but 
also their ability to stand up and walk.
4.5. Neuromuscular electrical stimulation 
Neuromuscular electrical stimulation (NMES) has been 
shown to be effective in treating and preventing GHS 
and pain associated with it.29 A recent meta-analysis of 
15 randomized controlled trials concluded that FES can 
be used to prevent or reduce shoulder subluxation early 
after stroke, however  it did not support the efficacy of 
use of FES for pain reduction, improvement in arm 
strength, movement, functional use, daily function, or 
quality of life after stroke.   NMES can be applied both 
in form of surface functional electrical stimulation (FES) 
or intra-muscular stimulation.46,47 The muscles targeted 
should include supraspinatus, long head of biceps and 
the posterior deltoid muscle. The NMES should be 
applied as early as possible because early application is 
associated with better outcomes and late application 
might not be as much effective.48 Since FES is not 
widely available in most of the developing countries 
including Pakistan, so the authors recommend early 
and regular use of surface electrical muscle 
stimulations in post stroke patients to promote motor 
recovery and prevent muscle wasting.  
4.6. Robotic Devices 
The role of robotic technology in the neurological 
rehabilitation has expanded in the last decade.  Many 
devices have been developed and tested in post stroke 
patients. In small trial of 18 patients, the robotic 
protocol effectively treated the shoulder subluxation. 
This robotic treatment additionally can lead to 
decreased spasticity, which may further increase use of 
the affected extremity and possibly help prevent 
complications such as adhesive capsulitis50.
5. CONCLUSION:
Shoulder subluxation is an important complication in 
post stroke patients, which can adversely affect the 
rehabilitation outcome and lead to shoulder pain. It 
should be preempted and appropriate preventive 
measures must be taken to avoid it. These include 
proper positioning, family and caregiver education, 
provision of adequate shoulder support and early 
introduction of neuromuscular approaches. Since the 
low tone in early recovery phase makes the surrounding 
muscles, tendons and ligaments more susceptible to 
damage. Thus, it is important to prevent subluxation in 
the early stages of recovery.
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